Department of Nutritional Sciences, Faculty of Medicine, University of Toronto; and with the Division of Endocrinology & Metabolism; the Department of Medicine; the Li Ka Shing Knowledge Institute; and the Toronto 3D Knowledge Synthesis & Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre; St. Michael's Hospital, Toronto, Ontario, Canada.
Nutr Rev. 2020 Aug 1;78(Suppl 1):69-77. doi: 10.1093/nutrit/nuz082.
Carbohydrates are increasingly being implicated in the epidemics of obesity, diabetes, and their downstream cardiometabolic diseases. The "carbohydrate-insulin model" has been proposed to explain this role of carbohydrates. It posits that a high intake of carbohydrate induces endocrine deregulation marked by hyperinsulinemia, leading to energy partitioning with increased storage of energy in adipose tissue resulting in adaptive increases in food intake and decreases in energy expenditure. Whether all carbohydrate foods under real-world feeding conditions directly contribute to weight gain and its complications or whether this model can explain these clinical phenomena requires close inspection. The aim of this review is to assess the evidence for the role of carbohydrate quantity vs quality in cardiometabolic health. Although the clinical investigations of the "carbohydrate-insulin model" have shown the requisite decreases in insulin secretion and increases in fat oxidation, there has been a failure to achieve the expected fat loss under low-carbohydrate feeding. Systematic reviews with pairwise and network meta-analyses of the best available evidence have failed to show the superiority of low-carbohydrate diets on long-term clinical weight loss outcomes or that all sources of carbohydrate behave equally. High-carbohydrate diets that emphasize foods containing important nutrients and substances, including high-quality carbohydrate such as whole grains (especially oats and barley), pulses, or fruit; low glycemic index and load; or high fiber (especially viscous fiber sources) decrease intermediate cardiometabolic risk factors in randomized trials and are associated with weight loss and decreased incidence of diabetes, cardiovascular disease, and cardiovascular mortality in prospective cohort studies. The evidence for sugars as a marker of carbohydrate quality appears to be highly dependent on energy control (comparator) and food source (matrix), with sugar-sweetened beverages providing excess energy showing evidence of harm, and with high-quality carbohydrate food sources containing sugars such as fruit, 100% fruit juice, yogurt, and breakfast cereals showing evidence of benefit in energy-matched substitutions for refined starches (low-quality carbohydrate food sources). These data reflect the current shift in dietary guidance that allows for flexibility in the proportion of macronutrients (including carbohydrates) in the diet, with a focus on quality over quantity and dietary patterns over single nutrients.
碳水化合物在肥胖、糖尿病及其下游心血管代谢疾病的流行中越来越受到关注。“碳水化合物-胰岛素模型”被提出以解释碳水化合物的这种作用。该模型假设,高碳水化合物的摄入会导致内分泌失调,表现为高胰岛素血症,导致能量分配,脂肪组织中能量储存增加,从而导致适应性地增加食物摄入和减少能量消耗。在现实喂养条件下,所有碳水化合物食物是否直接导致体重增加及其并发症,或者该模型是否可以解释这些临床现象,这需要仔细检查。本综述的目的是评估碳水化合物数量与质量对心血管代谢健康的作用的证据。尽管“碳水化合物-胰岛素模型”的临床研究表明胰岛素分泌减少和脂肪氧化增加,但在低碳水化合物喂养下未能实现预期的脂肪损失。对最佳现有证据进行的系统评价和网络荟萃分析显示,低碳水化合物饮食在长期临床体重减轻结果上没有优势,也没有证据表明所有碳水化合物来源的作用都相同。强调含有重要营养物质和物质的碳水化合物食物的高碳水化合物饮食,包括全谷物(尤其是燕麦和大麦)、豆类或水果等高质量碳水化合物;低血糖指数和负荷;或高纤维(尤其是粘性纤维来源),可减少随机试验中的中间心血管代谢危险因素,并与前瞻性队列研究中的体重减轻和糖尿病、心血管疾病和心血管死亡率降低相关。糖作为碳水化合物质量标志物的证据似乎高度依赖于能量控制(对照)和食物来源(基质),含糖饮料提供过多能量的证据表明存在危害,而高质量碳水化合物食物来源,如水果、100%果汁、酸奶和早餐麦片,在精制淀粉(低质量碳水化合物食物来源)的能量匹配替代物中显示出益处的证据。这些数据反映了饮食指导的当前转变,即在饮食中允许宏量营养素(包括碳水化合物)的比例具有一定的灵活性,重点是质量而不是数量,以及饮食模式而不是单一营养素。